• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by eXp World Holdings Inc. (Amendment)

    1/25/22 11:01:37 AM ET
    $EXPI
    Real Estate
    Finance
    Get the next $EXPI alert in real time by email
    SC 13D/A 1 expi-20220125xsc13da.htm SC 13D/A

    ​

    ​

    ​

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 13D/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 4)*

    A picture containing text, sign, clipart

Description automatically generated

    EXP WORLD HOLDINGS, INC.

    (Name of Issuer)

    ​

    ​

    ​

    ​

    Common Stock, $0.00001 Par Value

    ​

    ​

    (Title of Class of Securities)

    ​

    ​

    ​

    ​

    ​

    ​

    30212W100

    ​

    ​

    (CUSIP Number)

    ​

    ​

    ​

    ​

    Glenn Sanford

    Penny Sanford

    Jason Gesing

    336 36th Street

    Eugene Frederick

    Bellingham, WA 98225

    2219 Rimland Drive, Suite 301

    Tel: (360) 393-1853

    Bellingham, WA 98226

    ​

    Tel (360) 685-4206

    ​

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    Copy to: Christopher J. Voss K&L Gates LLP

    925 Fourth Avenue, Suite 2900

    Seattle, Washington 98104

    Tel: (206) 370-7609

    ​

    ​

    ​

    ​

    December 31, 2021

    ​

    ​

    (Date of Event which Requires Filing of this Statement)

    ​

    ​

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d -1(e), 240.13d -1(f) or 240.13d -1(g), check the following box [ ].

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Act”), or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    ​


    SCHEDULE 13D/A

    ​

    ​

    CUSIP No. 30212W100

    ​

    1

    NAMES OF REPORTING PERSONS

    ​

    Glenn D. Sanford

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

    ​

    (a)
    [X]
    (b)
    [ ]

    3

    SEC USE ONLY

    4

    SOURCE OF FUNDS (See Instructions)

    ​

    Not Applicable

    5

    CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

    ​

    [ ]

    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    ​

    United States

    ​

    7

    SOLE VOTING POWER

    ​

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

    WITH

    ​

    44,806,998 shares of common stock (1)

    8

    SHARED VOTING POWER

    ​

    267,676 shares of common stock(2)

    9

    SOLE DISPOSITIVE POWER

    ​

    44,806,998 shares of common stock(1)

    10

    SHARED DISPOSITIVE POWER

    ​

    ​

    267,676 shares of common stock(2)

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    ​

    45,074,674 shares of common stock

    12

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

    ​

    [ ]

    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    ​

    30.3%(3)

    14

    TYPE OF REPORTING PERSON (See Instructions)

    ​

    IN

    ​

    (1)Includes 42,302,014 shares of common stock and stock options exercisable for an aggregate of 2,504,984 shares of our common stock.
    (2)Shares held by other members of Glenn D. Sanford’s household.
    (3)Based on 148,764,592 shares of common stock issued and outstanding as of December 31, 2021.

    ​

    ​

    ​

    ​


    SCHEDULE 13D/A

    CUSIP No. 30212W100

    ​

    1

    NAMES OF REPORTING PERSONS

    ​

    Penny Sanford

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    ​

    (a)
    [X]
    (b)
    [ ]

    3

    SEC USE ONLY

    4

    SOURCE OF FUNDS (See Instructions)

    ​

    Not Applicable

    5

    CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

    ​

    [ ]

    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    ​

    United States

    ​

    7

    SOLE VOTING POWER

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

    WITH

    ​

    27,884,043 shares of common stock

    8

    SHARED VOTING POWER

    ​

    0

    9

    SOLE DISPOSITIVE POWER

    ​

    27,884,043 shares of common stock

    10

    SHARED DISPOSITIVE POWER

    ​

    ​

    0

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    ​

    27,884,043 shares of common stock

    12

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

    ​

    [ ]

    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    ​

    18.7%(1)

    14

    TYPE OF REPORTING PERSON (See Instructions)

    ​

    IN

    ​

    (1)Based on 148,764,592 shares of common stock issued and outstanding as of December 31, 2021.

    ​


    ​

    SCHEDULE 13D/A

    CUSIP No. 30212W100

    ​

    1

    NAMES OF REPORTING PERSONS

    ​

    Jason Gesing

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    ​

    (a)
    [X]
    (b)
    [ ]

    3

    SEC USE ONLY

    4

    SOURCE OF FUNDS (See Instructions)

    ​

    Not Applicable

    5

    CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

    ​

    [ ]

    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    ​

    United States

    ​

    7

    SOLE VOTING POWER

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

    WITH

    ​

    2,544,812 shares of common stock(1)

    8

    SHARED VOTING POWER

    ​

    0

    9

    SOLE DISPOSITIVE POWER

    ​

    2,544,812 shares of common stock(1)

    10

    SHARED DISPOSITIVE POWER

    ​

    ​

    0

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    ​

    2,544,812 shares of common stock

    12

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

    ​

    [ ]

    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    ​

    1.7%(2)

    14

    TYPE OF REPORTING PERSON (See Instructions)

    ​

    IN

    (1) Includes 2,182,312 shares of common stock and stock options exercisable for an aggregate of 362,500 shares of common stock.

    (2) Based on 148,764,592 shares of common stock issued and outstanding as of December 31, 2021.

    ​


    ​

    SCHEDULE 13D/A

    CUSIP No. 30212W100

    ​

    1

    NAMES OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

    ​

    Eugene Frederick

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    ​

    (a)
    [X]
    (b)
    [ ]

    3

    SEC USE ONLY

    4

    SOURCE OF FUNDS (See Instructions)

    ​

    Not Applicable

    5

    CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)

    ​

    [ ]

    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    ​

    United States

    ​

    7

    SOLE VOTING POWER

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON

    WITH

    ​

    5,257,624 shares of common stock (1)

    8

    SHARED VOTING POWER

    ​

    22,718 shares of common stock (2)

    9

    SOLE DISPOSITIVE POWER

    ​

    5,257,624 shares of common stock (1)

    10

    SHARED DISPOSITIVE POWER

    ​

    ​

    22,718 shares of common stock (2)

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    ​

    5,280,342 shares of common stock

    12

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)

    ​

    [ ]

    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    ​

    3.5%(3)

    14

    TYPE OF REPORTING PERSON (See Instructions)

    ​

    IN

    (1) Includes 5,257,564 shares of common stock and stock options exercisable for an aggregate of 60 shares of common stock.

    (2) Shares held by other members of the Eugene Frederick’s household.

    (3) Based on 148,764,592 shares of common stock issued and outstanding as of December 31, 2021.

    ​


    Explanatory Note

    This Amendment No. 4 to Schedule 13D (“Amendment No. 4”) amends and supplements the statement on Schedule 13D filed with the Securities and Exchange Commission on June 11, 2017 as amended by that certain Amendment No. 1 to Schedule 13D filed on March 8, 2021 (“Amendment No. 1”), as further amended by that certain Amendment No. 2 to Schedule 13D filed on April 23, 2021 (“Amendment No. 2”), and as further amended by that certain Amendement No. 3 to Schedule 13D filed on August 24, 2021 (as amended, the “Schedule 13D”). This Amendment No. 4 is being filed to reflect subsequent acquisitions and dispositions of shares of Common Stock by Mr. Sanford, Mr. Gesing, Mr. Frederick, Ms. Sanford and their reported households, including dispositions pursuant to their respective 10b5-1 Sale Plans. Information reported in the Schedule 13D remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment No. 4.  Capitalized terms used herein and not otherwise defined in this Amendment No. 4 have the meanings set forth in the Schedule 13D.

    Item 5. Interest in Securities of the Issuer

    (a)See Items 11 and 13 of the cover pages to this Schedule 13D for the aggregate number of shares of Common Shares and percentage of Common Shares beneficially owned by each of the Reporting Persons.

    ​

    As of December 31, 2021, the Reporting Persons as a group are the beneficial owners of 80,783,871 shares of Common Stock. Such shares of Common Stock represent beneficial ownership of 54.3% of outstanding shares of Common Stock.

    ​

    By virtue of the relationship described in Amendment No. 1, the Reporting Persons may be deemed to constitute a “group” within the meaning of Rule 13d-5 under the Act. As a member of a group, each Reporting Person may be deemed to share voting and dispositive power with respect to, and therefore beneficially own, the securities of the Company beneficially owned by members of the group as a whole. The filing of this Statement shall not be construed as an admission that the Reporting Persons beneficially own those securities held by another member of such group. In addition, each Reporting Person expressly disclaims beneficial ownership of any securities reported herein except to the extent such Reporting Person actually exercises voting or dispositive power with respect to such securities.

    ​

    (a)See items 7 through 10 of the cover pages to this Schedule 13D for the number of shares of Common Stock beneficially owned by each of the Reporting Persons as to which there is sole power to vote or to direct the vote, shared power to vote or to direct the vote and sole or shared power to dispose or to direct the disposition.
    (b)Schedule A hereto sets forth certain information with respect to transactions by the Reporting Persons in shares of Common Stock during the past 60 days.
    (c)Except as set forth in this Schedule 13D, to the knowledge of the Reporting Persons, no person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, securities covered by this Schedule 13D.

    ​

    (d)Not applicable.

    ​

    ​

    ​

    ​


    SIGNATURES

    ​

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    ​

    ​

    ​

    ​

    Dated: January 25, 2022

    ​

    /s/ Glenn Sanford

    ​

    ​

    Glenn Sanford

    ​

    ​

    ​

    Dated: January 25, 2022

    ​

    /s/ Penny Sanford

    ​

    ​

    Penny Sanford

    ​

    ​

    ​

    Dated: January 25, 2022

    ​

    /s/ Jason Gesing

    ​

    ​

    Jason Gesing

    ​

    ​

    ​

    Dated: January 25, 2022

    ​

    /s/ Eugene Frederick

    ​

    ​

    Eugene Frederick

    ​

    The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

    Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).

    ​


    SCHEDULE A

    Transactions in Shares of Common Stock in the last 60 days

    Nature of the Transaction

     

    Amount of Shares

    Purchased/(Sold)

     

    Price ($)

     

    Date of

    Purchase/Sale

     

    Glenn Sanford

    ​

    ​

    ​

    ​

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    01/20/2022

    Sale of Common Stock1

    ​

    (4,298)

    ​

    27.01892

    ​

    01/20/2022

    Sale of Common Stock3

    ​

    (4,702)

    ​

    27.90244

    ​

    01/20/2022

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    01/21/2022

    Sale of Common Stock5

    ​

    (4,272)

    ​

    25.28726

    ​

    01/21/2022

    Sale of Common Stock7

    ​

    (4,728)

    ​

    26.07758

    ​

    01/21/2022

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    01/20/2022

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    01/21/2022

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    01/18/2022

    Sale of Common Stock9

    ​

    (6,982)

    ​

    27.216110

    ​

    01/18/2022

    Sale of Common Stock11

    ​

    (2,018)

    ​

    28.208512

    ​

    01/18/2022

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    01/19/2022

    1 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.54 to $27.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    3 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.54 to $28.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    5 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    6 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.82 to $25.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    7 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    8 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.83 to $26.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    9 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    10 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.74 to $27.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    11 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    12 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.88 to $28.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.


    Sale of Common Stock13

    ​

    (9,000)

    ​

    26.987614

    ​

    01/19/2022

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    01/18/2022

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    01/19/2022

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    01/13/2022

    Sale of Common Stock15

    ​

    (8,296)

    ​

    29.7016

    ​

    01/13/2022

    Sale of Common Stock17

    ​

    (704)

    ​

    30.252618

    ​

    01/13/2022

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    01/14/2022

    Sale of Common Stock19

    ​

    (8,800)

    ​

    28.955520

    ​

    01/14/2022

    Sale of Common Stock21

    ​

    (200)

    ​

    29.5422

    ​

    01/14/2022

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    01/13/2022

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    01/14/2022

    ​

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    01/11/2022

    Sale of Common Stock23

    ​

    (1,692)

    ​

    28.344724

    ​

    01/11/2022

    Sale of Common Stock25

    ​

    (2,100)

    ​

    29.329826

    ​

    01/11/2022

    Sale of Common Stock27

    ​

    (5,208)

    ​

    30.325828

    ​

    01/11/2022

    13 The sale was effected pursuant to a preexisitng Rule 10b5-1 trading plan adopted by the reporting person.

    14 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.48 to $27.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    15 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    16 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.19 to $30.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    17 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    18 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.20 to $30.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    19 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    20 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.52 to $29.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    21 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    22 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.52 to $29.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    23 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    24 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.875 to $28.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    25 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    26 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.90 to $29.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    27 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    28 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.94 to $30.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.


    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    01/12/2022

    Sale of Common Stock29

    ​

    (8,434)

    ​

    30.496630

    ​

    01/12/2022

    Sale of Common Stock31

    ​

    (566)

    ​

    31.217632

    ​

    01/12/2022

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    01/11/2022

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    01/12/2022

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    01/07/2022

    Sale of Common Stock33

    ​

    (7,628)

    ​

    28.762634

    ​

    01/07/2022

    Sale of Common Stock35

    ​

    (1,372)

    ​

    29.612536

    ​

    01/07/2022

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    01/10/2022

    Sale of Common Stock37

    ​

    (7,414)

    ​

    26.935138

    ​

    01/10/2022

    Sale of Common Stock39

    ​

    (1,586)

    ​

    27.581440

    ​

    01/10/2022

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    01/07/2022

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    01/10/2022

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    01/05/2022

    Sale of Common Stock41

    ​

    (3,168)

    ​

    29.440542

    ​

    01/05/2022

    29 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    30 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.12 to $31.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    31 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    32 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.12 to $31.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    33 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    34 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.30 to $29.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    35 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    36 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.30 to $30.075, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    37 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    38 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.45 to $27.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    39 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    40 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.46 to $27.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    41 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    42 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.06 to $30.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.


    Sale of Common Stock43

    ​

    (4,732)

    ​

    30.675444

    ​

    01/05/2022

    Sale of Common Stock45

    ​

    (1,100)

    ​

    31.3146

    ​

    01/05/2022

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    01/06/2022

    Sale of Common Stock47

    ​

    (3,274)

    ​

    28.581848

    ​

    01/06/2022

    Sale of Common Stock49

    ​

    (5,726)

    ​

    29.270250

    ​

    01/06/2022

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    01/05/2022

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    01/06/2022

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    01/03/2022

    Sale of Common Stock51

    ​

    (8,400)

    ​

    33.68652

    ​

    01/03/2022

    Sale of Common Stock53

    ​

    (600)

    ​

    34.331754

    ​

    01/03/2022

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    01/04/2022

    Sale of Common Stock55

    ​

    (7,448)

    ​

    31.654156

    ​

    01/04/2022

    Sale of Common Stock57

    ​

    (1,300)

    ​

    32.798558

    ​

    01/04/2022

    43 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    44 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.13 to $31.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    45 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    46 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.14 to $31.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    47 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    48 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.98 to $28.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    49 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    50 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.98 to $29.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    51 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    52 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.26 to $34.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    53 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    54 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.28 to $34.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    55 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    56 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.20 to $32.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    57 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    58 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.20 to $33.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.


    Sale of Common Stock59

    ​

    (252)

    ​

    33.442760

    ​

    01/04/2022

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    01/03/2022

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    01/04/2022

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    12/30/2021

    ​

    Sale of Common Stock61

    ​

    (986)

    ​

    34.011862

    ​

    12/30/2021

    Sale of Common Stock63

    ​

    (8,014)

    ​

    34.863564

    ​

    12/30/2021

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    12/31/2021

    Sale of Common Stock65

    ​

    (6,369)

    ​

    33.971666

    ​

    12/31/2021

    Sale of Common Stock67

    ​

    (2,531)

    ​

    35.072268

    ​

    12/31/2021

    Sale of Common Stock69

    ​

    (100)

    ​

    35.770

    ​

    12/31/2021

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    12/30/2021

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    12/31/2021

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    12/27/2021

    Sale of Common Stock71

    ​

    (8,549)

    ​

    35.830172

    ​

    12/27/2021

    Sale of Common Stock73

    ​

    (451)

    ​

    36.416374

    ​

    12/27/2021

    59 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    60 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.20 to $33.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    61 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    62 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.32 to $34.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    63 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    64 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.32 to $35.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    65 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    66 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.60 to $34.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    67 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    68 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.60 to $35.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    69 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    70 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.32 to $34.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    71 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    72 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.32 to $36.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    73 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    74 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.34 to $36.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.


    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    12/28/2021

    Sale of Common Stock75

    ​

    (6,545)

    ​

    34.552376

    ​

    12/28/2021

    Sale of Common Stock77

    ​

    (2,455)

    ​

    35.606278

    ​

    12/28/2021

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    12/29/2021

    Sale of Common Stock79

    ​

    (9,000)

    ​

    33.553980

    ​

    12/29/2021

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    12/27/2021

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    12/28/2021

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    12/29/2021

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    12/22/2021

    Sale of Common Stock81

    ​

    (9,000)

    ​

    35.677882

    ​

    12/22/2021

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    12/23/2021

    Sale of Common Stock83

    ​

    (3,195)

    ​

    35.554184

    ​

    12/23/2021

    Sale of Common Stock85

    ​

    (5,805)

    ​

    36.266886

    ​

    12/23/2021

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    12/22/2021

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    12/23/2021

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    12/20/2021

    Sale of Common Stock87

    ​

    (7,019)

    ​

    33.763288

    ​

    12/20/2021

    75 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    76 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.32 to $36.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    77 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    78 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.32 to $36.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    79 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    80 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.21 to $34.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    81 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    82 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.115 to $36.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    83 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    84 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.93 to $35.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    85 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    86 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.93 to $36.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    87 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    88 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.32 to $34.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.


    Sale of Common Stock89

    ​

    (1,981)

    ​

    34.521690

    ​

    12/20/2021

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    12/21/2021

    Sale of Common Stock91

    ​

    (3,200)

    ​

    34.63892

    ​

    12/21/2021

    Sale of Common Stock93

    ​

    (5,800)

    ​

    35.53394

    ​

    12/21/2021

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    12/20/2021

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    12/21/2021

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    12/16/2021

    Sale of Common Stock95

    ​

    (5,033)

    ​

    33.660996

    ​

    12/16/2021

    Sale of Common Stock97

    ​

    (3,867)

    ​

    34.476998

    ​

    12/16/2021

    Sale of Common Stock99

    ​

    (100)

    ​

    35.26100

    ​

    12/16/2021

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    12/17/2021

    Sale of Common Stock101

    ​

    (1,425)

    ​

    35.26102

    ​

    12/17/2021

    Sale of Common Stock103

    ​

    (1,600)

    ​

    35.26104

    ​

    12/17/2021

    89 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    90 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.30 to $34.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    91 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    92 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.11 to $35.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    93 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    94 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.11 to $35.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    95 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    96 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.18 to $34.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    97 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    98 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.18 to $35.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    99 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    100 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.32 to $33.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    101 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    102 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.43 to $34.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    103 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    104 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.44 to $35.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.


    Sale of Common Stock105

    ​

    (5,975)

    ​

    35.26106

    ​

    12/17/2021

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    12/16/2021

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    12/17/2021

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    12/14/2021

    Sale of Common Stock107

    ​

    (5,314)

    ​

    32.9106108

    ​

    12/14/2021

    Sale of Common Stock109

    ​

    (3,686)

    ​

    33.3927110

    ​

    12/14/2021

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    12/15/2021

    Sale of Common Stock111

    ​

    (4,671)

    ​

    32.3904112

    ​

    12/15/2021

    Sale of Common Stock113

    ​

    (1,650)

    ​

    33.3245114

    ​

    12/15/2021

    Sale of Common Stock115

    ​

    (2,679)

    ​

    34.5366116

    ​

    12/15/2021

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    12/14/2021

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    12/15/2021

    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    12/10/2021

    Sale of Common Stock117

    ​

    (7,900)

    ​

    35.2573118

    ​

    12/10/2021

    Sale of Common Stock119

    ​

    (1,100)

    ​

    36.5441120

    ​

    12/10/2021

    105 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    106 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.20 to $33.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    107 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    108 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.20 to $33.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    109 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    110 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.20 to $33.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    111 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    112 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.01 to $32.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    113 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    114 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.01 to $33.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    115 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    116 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.25 to $34.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    117 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    118 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.84 to $35.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    119 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    120 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.


    Acquisition of Non-Derivative Securities

    ​

    9,000

    ​

    0.07

    ​

    12/13/2021

    Sale of Common Stock121

    ​

    (6,293)

    ​

    33.3225122

    ​

    12/13/2021

    Sale of Common Stock123

    ​

    (2,407)

    ​

    34.3873124

    ​

    12/13/2021

    Sale of Common Stock125

    ​

    (300)

    ​

    35.0267126

    ​

    12/13/2021

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    12/10/2021

    Exercise of Derivative Securities

    ​

    (9,000)

    ​

    0.07

    ​

    12/14/2021

    Sale of Common Stock127

    ​

    (10,822)

    ​

    37.2918128

    ​

    12/07/2021

    Sale of Common Stock129

    ​

    (1,678)

    ​

    37.7622130

    ​

    12/07/2021

    Sale of Common Stock131

    ​

    (5,754)

    ​

    35.6925132

    ​

    11/30/2021

    Sale of Common Stock133

    ​

    (6,146)

    ​

    36.7047134

    ​

    11/30/2021

    Sale of Common Stock135

    ​

    (600)

    ​

    37.2508136

    ​

    11/30/2021

    ​

    Penny Sanford

    ​

    ​

    ​

    ​

    Disposition of Non-Derivative Securities

    ​

    (60,607)

    ​

    0.00

    ​

    12/31/2021

    121 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    122 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.94 to $33.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    123 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    124 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.95 to $34.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    125 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    126 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    127 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    128 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.66 to $37.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    129 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    130 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.66 to $37.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    131 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    132 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.14 to $36.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    133 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    134 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.15 to $37.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    135 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    136 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.15 to $37.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.


    Sale of Common Stock137

    ​

    (39,700)

    ​

    26.9878138

    ​

    01/19/2022

    Sale of Common Stock139

    ​

    (300)

    ​

    27.5117140

    ​

    01/19/2022

    Sale of Common Stock141

    ​

    (15,249)

    ​

    34.7098142

    ​

    1/21/2021

    Sale of Common Stock143

    ​

    (24,751)

    ​

    35.5452144

    ​

    12/21/2021

    ​

    Jason Gesing

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Sale of Common Stock145

    ​

    (39,400)

    ​

    26.8674146

    ​

    01/10/2022

    Sale of Common Stock147

    ​

    (600)

    ​

    27.47148

    ​

    01/10/2022

    Disposition of Non-Derivative Securities

    ​

    (2,860)

    ​

    0.00

    ​

    12/30/2021

    Acquisition of Non-Derivative Securities

    ​

    25,000

    ​

    0.08

    ​

    12/13/2021

    Exercise of Derivative Securities

    ​

    (25,000)

    ​

    0.08

    ​

    12/13/2021

    Sale of Common Stock149

    ​

    (26,013)

    ​

    35.2832150

    ​

    12/10/2021

    Sale of Common Stock151

    ​

    (12,383)

    ​

    36.5851152

    ​

    12/10/2021

    137 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    138 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.47 to $27.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    139 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    140 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.51 to $27.515, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    141 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    142 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.06 to $35.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    143 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    144 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.06 to $35.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    145 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    146 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.45 to $27.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    147 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    148 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.46 to $27.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    149 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    150 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.92 to $35.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    151 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    152 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.98 to $36.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.


    Sale of Common Stock153

    ​

    (1,604)

    ​

    37.0416154

    ​

    12/10/2021

    Exercise of Derivative Securities155

    ​

    (8)

    ​

    0.00

    ​

    11/30/2021

    ​

    Eugene Frederick

    ​

    ​

    ​

    ​

    Restricted Stock Units issued under the Issuer’s Real Estate Agent Growth Incentive Program156/157

    ​

    22

    ​

    0.00

    ​

    12/31/2021

    Common Stock issued as Director Compensation158

    ​

    60

    ​

    0.00

    ​

    12/31/2021

    Restricted Stock Units issued under the Issuer’s Real Estate Agent Growth Incentive Program159/160

    ​

    48

    ​

    0.00

    ​

    11/30/2021

    Common Stock issued as Director Compensation161

    ​

    55

    ​

    0.00

    ​

    11/30/2021

    Common Stock issued under the Issuer’s 2015 Agent Equity Program162

    ​

    2

    ​

    46.44

    ​

    11/30/2021

    ​

    153 The sale was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person.

    154 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.03 to $37.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

    155 Represents Restricted Stock Units issued under the Issuer’s Real Estate Agent Growth Incentive Program. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer’s Common Stock and vests three years after the date of grant.

    156 Includes unvested restricted stock units.

    157 Represents Restricted Stock Units issued under the Issuer’s Real Estate Agent Growth Incentive Program. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer’s Common Stock and vests three years after the date of grant.

    158 These shares were issued to the reporting person as compensation for his services as a director.

    159 Includes unvested restricted stock units.

    160 Represents Restricted Stock Units issued under the Issuer’s Real Estate Agent Growth Incentive Program. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer’s Common Stock and vests three years after the date of grant.

    161 These shares were issued to the reporting person as compensation for his services as a director.

    162 These shares were issued to the reporting person under the Issuer’s 2015 Agent Equity Program.


    Get the next $EXPI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EXPI

    DatePrice TargetRatingAnalyst
    5/29/2025$10.75Neutral → Buy
    DA Davidson
    7/23/2024Sell → Neutral
    BTIG Research
    7/18/2023$14.00Sell
    BTIG Research
    2/25/2022$63.00 → $45.00Buy
    DA Davidson
    11/4/2021$66.00 → $63.00Buy
    DA Davidson
    8/5/2021$62.00 → $66.00Buy
    DA Davidson
    7/21/2021$53.00Buy
    Berenberg
    More analyst ratings

    $EXPI
    SEC Filings

    See more
    • eXp World Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure

      8-K - eXp World Holdings, Inc. (0001495932) (Filer)

      5/28/25 8:00:14 AM ET
      $EXPI
      Real Estate
      Finance
    • SEC Form 144 filed by eXp World Holdings Inc.

      144 - eXp World Holdings, Inc. (0001495932) (Subject)

      5/12/25 4:06:28 PM ET
      $EXPI
      Real Estate
      Finance
    • SEC Form 10-Q filed by eXp World Holdings Inc.

      10-Q - eXp World Holdings, Inc. (0001495932) (Filer)

      5/6/25 4:10:46 PM ET
      $EXPI
      Real Estate
      Finance

    $EXPI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • From a $91M Year to a Bold New Chapter: Costanza Genoese Zerbi Joins eXp Realty

      BELLINGHAM, Wash., June 04, 2025 (GLOBE NEWSWIRE) -- eXp Realty®, "the most agent-centric real estate brokerage on the planet™" and the core subsidiary of eXp World Holdings, Inc. (NASDAQ:EXPI), today announced that Costanza Genoese Zerbi, a nationally ranked top producer and founder of Costanza Genoese Zerbi & Associates in Long Beach, California, has joined its growing network of elite agents. A two-time Boston Marathon finisher and nationally ranked top producer, Costanza brings nearly a decade of experience, global insight, and an unmistakable energy to her real estate business. She closed over $91 million in a single year and in 2024, she finished strong with $65 million in volume

      6/4/25 12:00:00 PM ET
      $EXPI
      Real Estate
      Finance
    • Creative Powerhouse and Cultural Icon Mindy Kaling to Headline eXpcon Miami 2025

      BELLINGHAM, Wash., May 22, 2025 (GLOBE NEWSWIRE) -- eXp Realty®, the most agent-centric real estate brokerage on the planet™ and the core subsidiary of eXp World Holdings, Inc. (NASDAQ:EXPI), today announced that award-winning writer, producer, actor and best-selling author Mindy Kaling will deliver the keynote address at eXpcon™ 2025, taking place Oct. 20–22 at the Miami Beach Convention Center. Kaling, known for redefining comedy and storytelling through hit series including The Office, The Mindy Project, Never Have I Ever and Running Point, brings a unique and inspiring voice to the stage. Her work spans television, literature and film, and her influence continues to shape modern

      5/22/25 12:00:00 PM ET
      $EXPI
      Real Estate
      Finance
    • Top Arizona Team Led by Scott Kumler Joins eXp Realty, Bringing $80M in Volume

      BELLINGHAM, Wash., May 21, 2025 (GLOBE NEWSWIRE) -- eXp Realty®, "the most agent-centric real estate brokerage on the planet™" and the core subsidiary of eXp World Holdings, Inc. (NASDAQ:EXPI), today announced that top-producing Arizona team leader Scott Kumler and The Kumler Group have joined the company. Formerly with My Home Group, where his 53-member team ranked among the top five, The Kumler Group closed over $80 million in volume across 192 transactions in 2024 alone. "My goal is to give unparalleled value and support to our agents," said Kumler. "After months of research, it was clear that eXp was the best place to deliver that." The move comes under the sponsorship of Joshua

      5/21/25 12:00:00 PM ET
      $EXPI
      Real Estate
      Finance

    $EXPI
    Leadership Updates

    Live Leadership Updates

    See more
    • eXp Realty Launches in Ecuador, Onboards Country's Top Real Estate Sales Team as Kléver Guanoluisa Torres Leads Latin America Growth Surge

      BELLINGHAM, Wash., May 16, 2025 (GLOBE NEWSWIRE) -- eXp Realty®, the world's largest independent real estate brokerage and a core subsidiary of eXp World Holdings, Inc. (NASDAQ:EXPI), today announced the official launch of its operations in Ecuador, furthering the company's rapid expansion across Latin America. The move is led by Kléver Guanoluisa Torres, one of the country's most influential real estate professionals, who previously led Ecuador's top-performing team at RE/MAX. Kléver brings nearly 30 years of experience in real estate, coaching and business development. He has trained more than 2,000 agents across Latin America and is widely recognized for his leadership approach focus

      5/16/25 12:00:00 PM ET
      $EXPI
      Real Estate
      Finance
    • eXp Realty Launches Land & Ranch Division, Elevating Agent Success in One of Real Estate's Most Lucrative Niches

      BELLINGHAM, Wash., May 08, 2025 (GLOBE NEWSWIRE) -- eXp Realty®, "the most agent-centric real estate brokerage on the planet™" and the core subsidiary of eXp World Holdings, Inc. (NASDAQ:EXPI), today announced the official launch of its Land & Ranch Division, a powerful new platform purpose-built to empower agents serving the growing demand for rural, recreational, and agricultural properties. With a unique blend of heritage-inspired branding and cutting-edge tools, the division sets a new industry standard for how land and ranch specialists grow their businesses, expand their reach, and deliver elevated client experiences. "Our launch of the Land & Ranch Division is yet another example

      5/8/25 12:00:00 PM ET
      $EXPI
      Real Estate
      Finance
    • eXp Realty Appoints Nadia Habib as Managing Director of eXp Realty Canada to Lead Continued Growth

      BELLINGHAM, Wash., April 14, 2025 (GLOBE NEWSWIRE) -- eXp Realty®, "the most agent-centric real estate brokerage on the plans et™" and the core subsidiary of eXp World Holdings, Inc. (NASDAQ:EXPI), is proud to announce the appointment of Nadia Habib as Managing Director of eXp Realty Canada, effective immediately. The announcement was made by Leo Pareja, CEO of eXp Realty during eXpcon Montréal. "Nadia has been a force in the Canadian market," said Pareja. "She leads with heart, delivers results, and has earned the trust of agents across the country. This new chapter is a big one, and with Nadia at the helm, I'm confident eXp Realty Canada will continue to raise the bar for what's p

      4/14/25 9:00:00 AM ET
      $EXPI
      Real Estate
      Finance

    $EXPI
    Financials

    Live finance-specific insights

    See more
    • eXp World Holdings Reports Q1 2025 Results

      BELLINGHAM, Wash., May 06, 2025 (GLOBE NEWSWIRE) -- eXp World Holdings, Inc. (NASDAQ:EXPI), "eXp" or the "Company", "the most agent-centric™" real estate brokerage on the planet and the core subsidiary of eXp World Holdings, Inc., today announced financial results for the first quarter ended March 31, 2025. "We're entering 2025 from a position of strength. eXp has built one of the most comprehensive, tech-enabled agent value stack in the industry – one that's driving record International agent productivity and empowering entrepreneurs at scale," said Glenn Sanford, Founder, Chairman and CEO of eXp World Holdings. "This quarter alone, we more than doubled our international revenue year-o

      5/6/25 4:15:00 PM ET
      $EXPI
      Real Estate
      Finance
    • eXp World Holdings Reports Q4 and Full-Year 2024 Results

      BELLINGHAM, Wash., Feb. 20, 2025 (GLOBE NEWSWIRE) -- eXp World Holdings, Inc. (NASDAQ:EXPI), or the "Company", the holding company for eXp Realty®, FrameVR.io and SUCCESS® Enterprises, today announced financial results for the fourth quarter and fiscal year ended Dec. 31, 2024. "At eXp, we redefine what's possible in real estate, with our agent-centric platform offering unlimited growth opportunities for agents," said Glenn Sanford, eXp World Holdings Founder, Chairman and CEO. "I'm especially proud that we issued 1.8 million shares to agents, at an estimated value of $22 million in 2024. We ended the year with strong momentum, with our top 10 U.S. agents closing over $100 million of tran

      2/20/25 4:15:00 PM ET
      $EXPI
      Real Estate
      Finance
    • eXp World Holdings Reports Q3 2024 Results

      BELLINGHAM, Wash., Nov. 07, 2024 (GLOBE NEWSWIRE) -- eXp World Holdings, Inc. (NASDAQ:EXPI), or the "Company", the holding company for eXp Realty®, FrameVR.io and SUCCESS® Enterprises, today announced financial results for the third quarter ended Sept. 30, 2024. "This is an exciting and pivotal time for eXp agents worldwide," said Glenn Sanford, eXp World Holdings Founder, Chairman and CEO. "We continue to operate the most innovative, agent-centric real estate brokerage on the planet, improving the agent value proposition by leveraging technology like generative AI to help eXp agents and employees work faster, better and smarter. Our competitive value proposition and continued strong ag

      11/7/24 4:15:00 PM ET
      $EXPI
      Real Estate
      Finance

    $EXPI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • eXp World Holdings upgraded by DA Davidson with a new price target

      DA Davidson upgraded eXp World Holdings from Neutral to Buy and set a new price target of $10.75

      5/29/25 8:13:13 AM ET
      $EXPI
      Real Estate
      Finance
    • eXp World Holdings upgraded by BTIG Research

      BTIG Research upgraded eXp World Holdings from Sell to Neutral

      7/23/24 6:28:16 AM ET
      $EXPI
      Real Estate
      Finance
    • BTIG Research initiated coverage on eXp World Holdings with a new price target

      BTIG Research initiated coverage of eXp World Holdings with a rating of Sell and set a new price target of $14.00

      7/18/23 7:35:34 AM ET
      $EXPI
      Real Estate
      Finance

    $EXPI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by eXp World Holdings Inc. (Amendment)

      SC 13G/A - EXP World Holdings, Inc. (0001495932) (Subject)

      2/13/24 5:04:35 PM ET
      $EXPI
      Real Estate
      Finance
    • SEC Form SC 13G filed by eXp World Holdings Inc.

      SC 13G - EXP World Holdings, Inc. (0001495932) (Subject)

      1/25/24 4:59:33 PM ET
      $EXPI
      Real Estate
      Finance
    • SEC Form SC 13D/A filed by eXp World Holdings Inc. (Amendment)

      SC 13D/A - EXP World Holdings, Inc. (0001495932) (Subject)

      1/12/24 9:00:36 AM ET
      $EXPI
      Real Estate
      Finance

    $EXPI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Weakley Monica was granted 179 shares, increasing direct ownership by 2% to 8,450 units (SEC Form 4)

      4 - eXp World Holdings, Inc. (0001495932) (Issuer)

      6/2/25 3:23:57 PM ET
      $EXPI
      Real Estate
      Finance
    • CEO and Chairman of the Board Sanford Glenn Darrel sold $199,628 worth of shares (25,000 units at $7.99), decreasing direct ownership by 0.06% to 39,628,400 units (SEC Form 4)

      4 - eXp World Holdings, Inc. (0001495932) (Issuer)

      5/20/25 11:36:38 AM ET
      $EXPI
      Real Estate
      Finance
    • Chief Marketing Officer Forsythe Wendy covered exercise/tax liability with 615 shares and converted options into 2,287 shares, increasing direct ownership by 76% to 3,872 units (SEC Form 4)

      4 - eXp World Holdings, Inc. (0001495932) (Issuer)

      5/19/25 10:41:59 AM ET
      $EXPI
      Real Estate
      Finance